Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Medical and Pediatric Oncology|January 1, 1990
Phase II trial of etoposide and doxorubicin in advanced head and neck cancerW J Gradishar, E E Vokes, M S Kies
Seminars in Oncology|June 13, 2001
Tamoxifen to raloxifene and beyondR M O'Regan, V C Jordan
Endocrine-Related Cancer|May 28, 2004
Farnesyl transferase inhibitors: the next targeted therapies for breast cancer?R M O'Regan, F R Khuri
Cancer|November 1, 1990
Chemotherapy-related hemolytic-uremic syndrome after the treatment of head and neck cancer. A case reportW J Gradishar, E E Vokes, K Ni, et al.
The American Journal of Managed Care|October 28, 1999
The cost effectiveness of tamoxifen in the prevention of breast cancerL L Noe, R V Becker, W J Gradishar, et al.
Blood|November 15, 1992
Clinical and cytogenetic responses to granulocyte-macrophage colony-stimulating factor in therapy-related myelodysplasiaW J Gradishar, M M Le Beau, R O'Laughlin, et al.
Oncology|June 6, 2000
A pilot trial of suramin in metastatic breast cancer to assess antiangiogenic activity in individual patientsW J Gradishar, G Soff, J Liu, et al.
Oncogene|February 17, 2015
ERK-regulated αB-crystallin induction by matrix detachment inhibits anoikis and promotes lung metastasis in vivoD Malin, E Strekalova, V Petrovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1995
Phase II study of all-trans-retinoic acid and alpha-interferon in patients with advanced non-small cell lung cancerI Athanasiadis, M S Kies, M Miller, et al.
American Journal of Clinical Oncology|October 1, 1992
The impact on survival by adjuvant chemotherapy and radiation therapy in stage II non-small-cell lung cancerW J Gradishar, R Mick, P C Hoffman, et al.
Pageof 6